(Q74503632)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Effect of combination with an acellular pertussis, diphtheria, tetanus vaccine on antibody response to Hib vaccine (PRP-T) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

P Heath

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

F Shackley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J MacLennan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

N Shearstone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

L Diggle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

H Griffiths

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

E R Moxon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Finn

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 April 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

number of pages

6

1 reference

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

637-642

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Acellular pertussis vaccine is licensed for infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type B conjugate vaccines given for primary immunisation by separate or mixed injection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

The impact of conjugate vaccine on carriage of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Clinical and immunologic responses to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants injected at 3, 5, 7, and 18 months of age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Evaluation of booster doses of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Responses of children to booster immunization with their primary conjugate Haemophilus influenzae type B vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Immunologic Priming by One Dose of Haemophilus influenzae Type b Conjugate Vaccine in Infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Induction of SerumHaemophilus influenzaeType B Capsular Antibodies in Adult Volunteers Fed Cross-ReactingEscherichia coli075:K100:H5

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Development of a guinea pig model to assess immunogenicity of Haemophilus influenzae type b capsular polysaccharide conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2984511-2

7 January 2021

10.1016/S0264-410X(97)84511-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9569476%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference